Doctors told Ray Hester he was in the beginning stages of Alzheimer’s, but a brain scan revealed instead he had LATE dementia. “There’s a certain amount of relief knowing that it’s not Alzheimer’s,” his wife, Sandy, said.
The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.
A trial of semaglutide, the miracle drug branded as Ozempic and Wegovy for diabetes and weight loss, failed to find any effect of the drug on cognition and functioning in people with mild cognitive impairment or dementia.
Young adults who engaged in a social media “detox” reported reductions in depression, anxiety and insomnia, though it was unclear how long the effects would last.
A neuroscientist, he employed a battery of high-tech tools in devising a fast-acting therapy that targets the area of the brain where depression originates.
Lab-grown “reductionist replicas” of the human brain are helping scientists understand fetal development and cognitive disorders, including autism. But ethical questions loom.
Login
